Overview
- 4 inspections across 4 sites are on record.
- 10 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-12-20.
At a glance
Inspections
4
Sites
4
Observations
10
Career since
Sep 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| ZENARA PHARMA PRIVATE LIMITED | 20 Dec 2019 | Human Drugs | On file |
| WES Pharma Inc. | 20 Dec 2019 | Human Drugs | View 483 → |
| Mission Pharmacal Company | 4 Apr 2019 | Human Drugs | View 483 → |
| Haimen Pharma Inc. | 8 Sep 2017 | Human Drugs | On file |
Sites inspected
ZENARA PHARMA PRIVATE LIMITEDHyderabad, India1 insp.
WES Pharma Inc.Westminster, United States1 insp.
Mission Pharmacal CompanyBoerne, United States1 insp.
Haimen Pharma Inc.Haimen City, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Anitha P Govada's 10 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site